In vivo suppression of SIV-mediated immune activation by a p38 MAPK inhibitor combined with ART
Saved in:
Main Authors: | A. Aldovini (Author), O. Chaudhary (Author), V. Narayan (Author), R. Veazey (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
by: Mark C. Bagley, et al.
Published: (2010) -
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
by: Yang Yang, et al.
Published: (2022) -
PP 2.14 - 00162 Elucidating the effects of combination therapy with Venetoclax and IAP inhibitor AZD5582 in SIV-infected, ART-suppressed macaques
by: B. Ukhueduan, et al.
Published: (2022) -
Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation
by: Qinwen Zheng, et al.
Published: (2023) -
p38 MAPK, microglial signaling, and neuropathic pain
by: Suter Marc R, et al.
Published: (2007)